Orthopediatrics (KIDS) Share-based Compensation Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.69% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 3.57% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -4.08% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 12.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 12.94% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 26.61% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 59.09% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 31.63% |
| 10 | Orthopediatrics | 394.83 Mn | 346.02 Mn | 43.39 Mn | 3.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.19% |
| Dec 31, 2025 | 13.58% |
| Sep 30, 2025 | 8.39% |
| Jun 30, 2025 | 78.70% |
| Mar 31, 2025 | 37.87% |
| Dec 31, 2024 | 41.54% |
| Sep 30, 2024 | 65.63% |
| Jun 30, 2024 | -14.96% |
| Mar 31, 2024 | 32.47% |
| Dec 31, 2023 | 61.49% |
| Sep 30, 2023 | 40.78% |
| Jun 30, 2023 | 95.25% |
| Mar 31, 2023 | 38.47% |
| Dec 31, 2022 | 1.73% |
| Sep 30, 2022 | 16.81% |
| Jun 30, 2022 | 25.09% |
| Mar 31, 2022 | 15.96% |
| Dec 31, 2021 | 12.67% |
| Sep 30, 2021 | 14.38% |
| Jun 30, 2021 | -43.29% |
| Mar 31, 2021 | 37.37% |
| Dec 31, 2020 | 109.90% |
| Sep 30, 2020 | 71.76% |
| Jun 30, 2020 | 260.55% |
| Mar 31, 2020 | 103.40% |
| Dec 31, 2019 | 147.20% |
| Sep 30, 2019 | 173.51% |
| Jun 30, 2019 | 52.42% |
| Mar 31, 2019 | -78.36% |
| Dec 31, 2018 | -88.07% |
| Sep 30, 2018 | -24.29% |
| Jun 30, 2018 | 17.01% |
| Mar 31, 2018 | 542.18% |
| Dec 31, 2017 | 699.00% |